KR20050034802A - Drink for withdrrawl of hangover and fabrication method thereof - Google Patents
Drink for withdrrawl of hangover and fabrication method thereof Download PDFInfo
- Publication number
- KR20050034802A KR20050034802A KR1020030070489A KR20030070489A KR20050034802A KR 20050034802 A KR20050034802 A KR 20050034802A KR 1020030070489 A KR1020030070489 A KR 1020030070489A KR 20030070489 A KR20030070489 A KR 20030070489A KR 20050034802 A KR20050034802 A KR 20050034802A
- Authority
- KR
- South Korea
- Prior art keywords
- hangover
- drink
- purified water
- concentrated extract
- dermis
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims abstract description 50
- 206010019133 Hangover Diseases 0.000 title claims abstract description 47
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 9
- 230000008569 process Effects 0.000 claims abstract description 40
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 claims abstract description 27
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 25
- 239000008213 purified water Substances 0.000 claims abstract description 24
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims abstract description 21
- 238000001914 filtration Methods 0.000 claims abstract description 20
- 210000004207 dermis Anatomy 0.000 claims abstract description 18
- 235000006679 Mentha X verticillata Nutrition 0.000 claims abstract description 16
- 235000002899 Mentha suaveolens Nutrition 0.000 claims abstract description 16
- 235000001636 Mentha x rotundifolia Nutrition 0.000 claims abstract description 16
- 235000011201 Ginkgo Nutrition 0.000 claims abstract description 14
- 241000218628 Ginkgo Species 0.000 claims abstract description 14
- 235000008100 Ginkgo biloba Nutrition 0.000 claims abstract description 14
- 239000007788 liquid Substances 0.000 claims abstract description 13
- 229960003080 taurine Drugs 0.000 claims abstract description 13
- 238000000605 extraction Methods 0.000 claims abstract description 12
- 239000000463 material Substances 0.000 claims abstract description 12
- 238000002156 mixing Methods 0.000 claims abstract description 11
- 239000011780 sodium chloride Substances 0.000 claims abstract description 11
- 235000002639 sodium chloride Nutrition 0.000 claims abstract description 11
- 229920000858 Cyclodextrin Polymers 0.000 claims abstract description 10
- 239000001116 FEMA 4028 Substances 0.000 claims abstract description 10
- 229930091371 Fructose Natural products 0.000 claims abstract description 10
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 claims abstract description 10
- 239000005715 Fructose Substances 0.000 claims abstract description 10
- UEDUENGHJMELGK-HYDKPPNVSA-N Stevioside Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UEDUENGHJMELGK-HYDKPPNVSA-N 0.000 claims abstract description 10
- 229930006000 Sucrose Natural products 0.000 claims abstract description 10
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims abstract description 10
- 235000015197 apple juice Nutrition 0.000 claims abstract description 10
- WHGYBXFWUBPSRW-FOUAGVGXSA-N beta-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO WHGYBXFWUBPSRW-FOUAGVGXSA-N 0.000 claims abstract description 10
- 235000011175 beta-cyclodextrine Nutrition 0.000 claims abstract description 10
- 229960004853 betadex Drugs 0.000 claims abstract description 10
- 239000001509 sodium citrate Substances 0.000 claims abstract description 10
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 claims abstract description 10
- 229940013618 stevioside Drugs 0.000 claims abstract description 10
- OHHNJQXIOPOJSC-UHFFFAOYSA-N stevioside Natural products CC1(CCCC2(C)C3(C)CCC4(CC3(CCC12C)CC4=C)OC5OC(CO)C(O)C(O)C5OC6OC(CO)C(O)C(O)C6O)C(=O)OC7OC(CO)C(O)C(O)C7O OHHNJQXIOPOJSC-UHFFFAOYSA-N 0.000 claims abstract description 10
- 235000019202 steviosides Nutrition 0.000 claims abstract description 10
- 229960002737 fructose Drugs 0.000 claims abstract description 9
- 229960002668 sodium chloride Drugs 0.000 claims abstract description 9
- 229960001790 sodium citrate Drugs 0.000 claims abstract description 9
- 235000011083 sodium citrates Nutrition 0.000 claims abstract description 9
- 238000004090 dissolution Methods 0.000 claims abstract description 8
- 230000006837 decompression Effects 0.000 claims abstract description 7
- 229940049906 glutamate Drugs 0.000 claims abstract description 6
- 238000005406 washing Methods 0.000 claims abstract description 5
- PXEDJBXQKAGXNJ-QTNFYWBSSA-L disodium L-glutamate Chemical compound [Na+].[Na+].[O-]C(=O)[C@@H](N)CCC([O-])=O PXEDJBXQKAGXNJ-QTNFYWBSSA-L 0.000 claims abstract description 4
- 239000000203 mixture Substances 0.000 claims abstract description 4
- 235000013923 monosodium glutamate Nutrition 0.000 claims abstract description 4
- 229940073490 sodium glutamate Drugs 0.000 claims abstract description 4
- 230000001954 sterilising effect Effects 0.000 claims description 10
- 238000004659 sterilization and disinfection Methods 0.000 claims description 8
- 238000007789 sealing Methods 0.000 claims description 7
- 239000000243 solution Substances 0.000 claims description 7
- 238000009928 pasteurization Methods 0.000 claims description 6
- 238000013329 compounding Methods 0.000 claims description 5
- 238000011049 filling Methods 0.000 claims description 5
- GYHNNYVSQQEPJS-UHFFFAOYSA-N Gallium Chemical compound [Ga] GYHNNYVSQQEPJS-UHFFFAOYSA-N 0.000 claims description 4
- 229910052733 gallium Inorganic materials 0.000 claims description 4
- 238000010438 heat treatment Methods 0.000 claims description 3
- 239000011259 mixed solution Substances 0.000 claims description 3
- 239000000645 desinfectant Substances 0.000 claims 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 34
- 235000019441 ethanol Nutrition 0.000 description 27
- 235000013361 beverage Nutrition 0.000 description 9
- 239000002504 physiological saline solution Substances 0.000 description 6
- 239000002994 raw material Substances 0.000 description 6
- 230000000052 comparative effect Effects 0.000 description 5
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 210000001156 gastric mucosa Anatomy 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 235000016257 Mentha pulegium Nutrition 0.000 description 2
- 244000246386 Mentha pulegium Species 0.000 description 2
- 235000004357 Mentha x piperita Nutrition 0.000 description 2
- 206010047700 Vomiting Diseases 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 230000035622 drinking Effects 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 238000000227 grinding Methods 0.000 description 2
- 235000001050 hortel pimenta Nutrition 0.000 description 2
- 238000009832 plasma treatment Methods 0.000 description 2
- 230000008673 vomiting Effects 0.000 description 2
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 206010008479 Chest Pain Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 208000019693 Lung disease Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 206010049816 Muscle tightness Diseases 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 231100000570 acute poisoning Toxicity 0.000 description 1
- 208000028505 alcohol-related disease Diseases 0.000 description 1
- 235000013334 alcoholic beverage Nutrition 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 230000005176 gastrointestinal motility Effects 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 239000002075 main ingredient Substances 0.000 description 1
- 230000009245 menopause Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 210000004165 myocardium Anatomy 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 230000036284 oxygen consumption Effects 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 206010036067 polydipsia Diseases 0.000 description 1
- 210000002460 smooth muscle Anatomy 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 239000011550 stock solution Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 230000008728 vascular permeability Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/20—Natural extracts
- A23V2250/21—Plant extracts
Landscapes
- Non-Alcoholic Beverages (AREA)
Abstract
본 발명은 숙취 해소용 음료에 있어서, 갈화, 진피, 은행, 박하의 혼합액에서 추출한 농축엑스 3 ~ 5 중량%와; 백설탕, 사과과즙, 타우린, 액상과당, 스테비오사이드, 염화나트륨, 구연산나트륨, 베타-시클로덱스트린, 소드-글루타메이트로 이루어진 군에서 선택된 적어도 4가지 이상으로 이루어진 부원료 13 ~ 17 중량%와; 정제수 80 ~ 82 중량%를 포함함을 특징으로 하는 숙취 해소용 음료를 제공한다.The present invention provides a hangover solution, 3 ~ 5% by weight of the extract extracted from the mixture of browning, dermis, ginkgo, mint; 13 to 17% by weight of an auxiliary material consisting of at least four or more selected from the group consisting of white sugar, apple juice, taurine, liquid fructose, stevioside, sodium chloride, sodium citrate, beta-cyclodextrin, and sodium glutamate; It provides a hangover solution characterized in that it comprises 80 to 82% by weight of purified water.
또한, 본 발명은 숙취 해소용 음료의 제조 방법에 있어서, 갈화, 진피, 은행, 박하를 세척한 후 정제수를 가하여 80 ~ 100℃에서 추출하는 추출 과정과; 상기 추출액을 여과한 후 60℃ 이하에서 감압 농축하여 농축엑스를 얻는 여과/감압 농축 과정과; 상기 농축엑스를 정제수에 용해시키는 용해 과정과; 상기 농축엑스가 용해된 정제수에 백설탕, 사과과즙, 타우린, 액상과당, 스테비오사이드, 염화나트륨, 구연산나트륨, 베타-시클로덱스트린, 소드-글루타메이트로 이루어진 군에서 선택된 적어도 4가지 이상으로 이루어진 부원료를 혼합한 후 여과하는 부원료 혼합/여과 과정을 포함함을 특징으로 하는 숙취 해소용 음료의 제조 방법을 제공한다. In addition, the present invention provides a method for producing a hangover-relieving drink, the extraction process of extracting at 80 ~ 100 ℃ by adding purified water after washing the browning, dermis, ginkgo, mint; Filtration / decompression concentration process of filtering the extract and concentrating under reduced pressure at 60 ° C. or lower to obtain a concentrated extract; A dissolution process of dissolving the concentrated extract in purified water; The concentrated extract is dissolved in purified water mixed with white sugar, apple juice, taurine, liquid fructose, stevioside, sodium chloride, sodium citrate, beta-cyclodextrin, at least four of the sub-elements selected from the group consisting of Saw-glutamate Provided is a method for preparing a hangover drink, characterized in that it comprises a secondary material mixing / filtration process to be filtered.
Description
본 발명은 숙취 해소용 음료에 관한 것으로서, 특히 갈화, 은행, 박하, 진피를 주원료로 하는 숙취 해소용 음료 및 그 제조 방법에 관한 것이다.BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a hangover-relieving beverage, and more particularly, to a hangover-removing beverage having a main ingredient such as browning, ginkgo, peppermint and dermis.
통상적으로, 알코올은 유기 화학물의 일종으로서, 에탄올(Ethanol), 메탄올(Methanol), 아이소프로프라놀(Isopropranol)을 포함한다. 우리가 술로서 음용하는 것은 에탄올이며, 상기 에탄올은 투명하고 휘발성이 있는 액체로 산화가 쉽게 되며, 특이한 냄새를 내고, 수용성이다. 에탄올은 탄소, 산소, 수소 원자로 구성된다. Typically, alcohol is a type of organic chemical, and includes ethanol, methanol, and isopropranol. What we drink as alcohol is ethanol, which is a transparent and volatile liquid that is easy to oxidize, has a peculiar smell, and is water soluble. Ethanol is composed of carbon, oxygen, and hydrogen atoms.
술은 지구상에 약 70만종으로 알려져 있으며, 이로 인한 폐해는 음주와 관련된 질환과 음주와 연관된 사고로 나눌 수 있다. 우리나라의 음주 문화는 과량의 알코올을 반복적으로 섭취함으로 만성적으로 노출되어 있으며, 이로 인하여 일상적인 생활에 영향을 미치는 것이 사회적인 문제이다.There are about 700,000 alcoholic beverages on the planet, and the damages can be divided into alcohol-related diseases and alcohol-related accidents. Drinking culture of Korea is chronically exposed by repeatedly ingesting excessive alcohol, and it is a social problem that affects daily life.
따라서, 최근 알코올의 독성으로 인한 폐단과 휴유증을 줄이고자 소위 숙취 해소와 관련된 기능성 음료들이 시중에 시판되고 있다. 또한, 음주에 따른 인체 부작용을 감소시키고 정상적인 일상 생활에 쉽게 복귀할 수 있기 위하여 숙취 해소용 음료를 이용한 혈중 알코올 농도를 감소시키고, 알코올 대사시 발생하는 부산물인 숙취원인을 해소시키려는 방안을 적용하고 있다. Therefore, recently, functional drinks associated with so-called hangover elimination are being marketed in order to reduce the pulmonary disease and the absence after the toxicity of alcohol. In addition, in order to reduce the side effects of drinking and to be able to return to normal daily life easily, it is applied to reduce the blood alcohol concentration by using hangover-removing drinks and to eliminate the causes of hangover, which are by-products of alcohol metabolism. .
상기와 같은 문제점을 해결하기 위하여 본 발명의 목적은 알콜의 급성중독 증상을 해소하고, 위점막 및 간장을 보호/보양하는 숙취 해소용 음료 및 그 제조 방법을 제공하는데 있다. In order to solve the above problems, an object of the present invention to solve the symptoms of acute poisoning of alcohol, and to provide a hangover-relieving beverage and a method of manufacturing the same to protect / supplement the gastric mucosa and liver.
상기와 같은 목적을 달성하기 위하여 본 발명은 숙취 해소용 음료에 있어서, 갈화, 진피, 은행, 박하의 혼합액에서 추출한 농축엑스 3 ~ 5 중량%와; 백설탕, 사과과즙, 타우린, 액상과당, 스테비오사이드, 염화나트륨, 구연산나트륨, 베타-시클로덱스트린, 소드-글루타메이트로 이루어진 군에서 선택된 적어도 4가지 이상으로 이루어진 부원료 13 ~ 17 중량%와; 정제수 80 ~ 82 중량%를 포함함을 특징으로 하는 숙취 해소용 음료를 제공한다.In order to achieve the above object, the present invention, in the beverage for hangover, concentrated extract 3 ~ 5% by weight extracted from the mixture of browning, dermis, ginkgo, mint; 13 to 17% by weight of an auxiliary material consisting of at least four or more selected from the group consisting of white sugar, apple juice, taurine, liquid fructose, stevioside, sodium chloride, sodium citrate, beta-cyclodextrin, and sodium glutamate; It provides a hangover solution characterized in that it comprises 80 to 82% by weight of purified water.
또한, 본 발명은 숙취 해소용 음료의 제조 방법에 있어서, 갈화, 진피, 은행, 박하를 세척한 후 정제수를 가하여 80 ~ 100℃에서 추출하는 추출 과정과; 상기 추출액을 여과한 후 60℃ 이하에서 감압 농축하여 농축엑스를 얻는 여과/감압 농축 과정과; 상기 농축엑스를 정제수에 용해시키는 용해 과정과; 상기 농축엑스가 용해된 정제수에 백설탕, 사과과즙, 타우린, 액상과당, 스테비오사이드, 염화나트륨, 구연산나트륨, 베타-시클로덱스트린, 소드-글루타메이트로 이루어진 군에서 선택된 적어도 4가지 이상으로 이루어진 부원료를 혼합한 후 여과하는 부원료 혼합/여과 과정을 포함함을 특징으로 하는 숙취 해소용 음료의 제조 방법을 제공한다. In addition, the present invention provides a method for producing a hangover-relieving drink, the extraction process of extracting at 80 ~ 100 ℃ by adding purified water after washing the browning, dermis, ginkgo, mint; Filtration / decompression concentration process of filtering the extract and concentrating under reduced pressure at 60 ° C. or lower to obtain a concentrated extract; A dissolution process of dissolving the concentrated extract in purified water; The concentrated extract is dissolved in purified water mixed with white sugar, apple juice, taurine, liquid fructose, stevioside, sodium chloride, sodium citrate, beta-cyclodextrin, at least four of the sub-elements selected from the group consisting of Saw-glutamate Provided is a method for preparing a hangover drink, characterized in that it comprises a secondary material mixing / filtration process to be filtered.
이하 본 발명의 바람직한 실시예를 첨부된 도면을 참조하여 상세히 설명하면 다음과 같다. 본 발명을 설명함에 있어서, 관련된 공지기능 혹은 구성에 대한 구체적인 설명이 본 발명의 요지를 불필요하게 흐릴 수 있다고 판단되는 경우 그 상세한 설명을 생략한다.Hereinafter, exemplary embodiments of the present invention will be described in detail with reference to the accompanying drawings. In the following description of the present invention, if it is determined that the detailed description of the related known function or configuration may unnecessarily obscure the subject matter of the present invention, the detailed description thereof will be omitted.
본 발명의 바람직한 실시예에 따른 숙취 해소용 음료는 농축엑스, 부원료 및 정제수로 이루어진다. Hangover drink according to a preferred embodiment of the present invention is composed of concentrated extract, secondary raw materials and purified water.
(1) 농축엑스(1) concentrated extract
상기 농축엑스는 갈화, 진피, 은행, 박하의 혼합액에 정제수를 가한 후 추출한 것으로서, 숙취 해소용 음료의 3 ~ 5 중량%를 차지하며, 바람직하게는 4 중량%를 차지하도록 조절한다. The concentrated extract is extracted after adding purified water to the mixed solution of browning, dermis, ginkgo, mint, and takes up 3 to 5% by weight of the hangover solution, preferably adjusted to take up 4% by weight.
상기 농축엑스는 갈화 12 ~ 13%, 진피 22 ~ 23%, 은행 32 ~ 33%, 박하 32 ~ 33%의 배합비로 이루어지며, 바람직하게는 갈화 13%, 진피 22.6%, 32.2%, 박하 32.2%로 이루어진다. The concentrated extract is composed of the compounding ratio of 12 to 13% gallium, 22 to 23% dermis, 32 to 33% ginkgo, 32 to 33% mint, preferably 13% gallium, 22.6% dermis, 32.2%, 32.2% mint Is made of.
상기 갈화는 맛이 달고 순한 약제로서, 술을 깨고 비장을 살려준다. 주로, 음주과다로 인한 두통, 현기증, 갈증, 가슴이 답답하고 신물을 토하는 등 위의 기를 상하게 하는 증상에 사용된다. The browning is a sweet and mild medicine that breaks the alcohol and saves the spleen. It is mainly used for symptoms such as headaches, dizziness, thirst, chest pains and vomiting due to excessive drinking.
상기 진피는 맵고, 쓴 맛을 가진 약제로서, 기를 순통하게 하며, 조중, 담을 삭일 뿐만 아니라 물고기, 게독을 해독하는 작용이 있다. The dermis is a spicy, bitter taste medicine, which helps to break up the group, and acts to detoxify the fish, crab, as well as to remove the weight and phlegm.
상기 은행은 맛이 달고, 쓰고, 떫고, 순하다. 약한 독성이 있고, 폐경에 속한다. The banks are sweet, bitter, steamed and mellow. It is mildly toxic and belongs to menopause.
상기 박하는 맵고, 찬 약제로서, 열을 내리고, 눈을 밝게 하며, 인후를 윤활하게 한다. The peppermint is a hot, cold medication that lowers heat, brightens the eyes, and lubricates the throat.
(2) 부원료 및 정제수(2) Side materials and purified water
상기 부원료는 백설탕, 사과과즙, 타우린, 액상과당, 스테비오사이드, 염화나트륨, 구연산나트륨, 베타-시클로덱스트린, 소드-글루타메이트로 이루어진 군에서 선택된 적어도 4가지 이상으로 이루어지며, 숙취 해소 음료의 13 ~ 17 중량%를 차지한다. The secondary raw material is composed of at least four or more selected from the group consisting of white sugar, apple juice, taurine, liquid fructose, stevioside, sodium chloride, sodium citrate, beta-cyclodextrin, sword-glutamate, 13 to 17 weight of the hangover Occupies%
상기 정제수는 숙취 해소 음료의 용매로 사용되며, 숙취 해소 음료의 80 ~ 82 중량%를 차지한다. The purified water is used as a solvent of the hangover-relieving beverage, and accounts for 80 to 82% by weight of the hangover-resolved beverage.
도 1은 본 발명의 바람직한 실시예에 따른 숙취 해소용 음료의 제조 방법을 나타낸 흐름도이다. 도 1에 도시된 바와 같이 본 발명의 바람직한 실시예에 따른 숙취 해소용 음료의 제조 방법은 추출 과정(S110), 여과/감압 농축 과정(S120), 용해 과정(S130) 및 부원료 혼합/여과 과정(S140)을 포함하고, 살균 처리 과정(S150), 충진/밀봉 과정(S160) 및 저온 살균 과정(S170)을 추가로 수행할 수 있다. 1 is a flow chart showing a method for producing a hangover drink in accordance with a preferred embodiment of the present invention. As shown in FIG. 1, the method for preparing a hangover drink according to a preferred embodiment of the present invention is an extraction process (S110), a filtration / decompression concentration (S120), a dissolution process (S130), and a subsidiary material mixing / filtration process ( S140), and the sterilization process (S150), filling / sealing process (S160) and pasteurization process (S170) may be further performed.
(1) 추출 과정(1) extraction process
상기 추출 과정(S110)은 주원료에 정제수를 가한 후 가열하여 농축엑스 원액을 추출하는 과정이다. The extraction process (S110) is a process of extracting concentrated extract stock solution by adding purified water to the main raw material and then heating it.
상기 추출 과정(S110)은 갈화, 진피, 은행, 박하를 세척한 후 10배의 정제수를 가하여 80 ~ 100℃에서 추출하여 이루어진다. The extraction process (S110) is made by extracting at 80 ~ 100 ℃ by adding 10 times purified water after washing the grinding, dermis, bank, mint.
상기 추출 과정(S110)은 갈화 12 ~ 13%, 진피 22 ~ 23%, 은행 32 ~ 33%, 박하 32 ~ 33%의 배합비를 유지하며, 바람직하게는 갈화 13%, 진피 22.6%, 32.2%, 박하 32.2%의 배합비를 유지한다. The extraction process (S110) maintains the compounding ratio of 12-13%, 22-23% dermis, 32-33% ginkgo, 32-33% mint, preferably 13%, 22.6%, 32.2% dermis, Maintain a blending ratio of 32.2% mint.
상기 추출 과정(S110)은 80 ~ 100℃에서 2시간동안 이루어지는 것이 바람직하다. The extraction process (S110) is preferably made for 2 hours at 80 ~ 100 ℃.
(2) 여과/감압 농축 과정(2) filtration / decompression concentration process
상기 여과/감압 농축 과정(S120)은 추출액을 여과한 후 60℃ 이하에서 감압 농축하여 농축엑스를 얻는 과정이다. The filtration / decompression concentration process (S120) is a process of obtaining a concentrated extract by concentrating under reduced pressure at 60 ℃ or less after filtering the extract.
(3) 용해 과정(3) dissolution process
상기 용해 과정(S130)은 감압 농축을 통해 얻어진 농축엑스를 정제수에 용해시키는 과정이다. The dissolution process (S130) is a process of dissolving the concentrated extract obtained through vacuum concentration in purified water.
(4) 부원료 혼합/여과 과정(4) auxiliary material mixing / filtration process
상기 부원료 혼합/여과 과정(S140)은 숙취 해소용 음료를 섭취하기 용이하도록 다양한 부원료를 첨가하는 과정이다. The secondary raw material mixing / filtration process (S140) is a process of adding a variety of secondary raw materials to facilitate the intake of the hangover solution.
상기 부원료 혼합/여과 과정(S140)은 농축엑스가 용해된 정제수에 백설탕, 사과과즙, 타우린, 액상과당, 스테비오사이드, 염화나트륨, 구연산나트륨, 베타-시클로덱스트린, 소드-글루타메이트로 이루어진 군에서 선택된 적어도 4가지 이상으로 이루어진 부원료를 혼합한 후 여과함으로써 이루어진다. The secondary raw material mixing / filtration process (S140) is at least 4 selected from the group consisting of white sugar, apple juice, taurine, liquid fructose, stevioside, sodium chloride, sodium citrate, beta-cyclodextrin, Saw-glutamate in purified water in which concentrated extract is dissolved It is made by mixing and then filtering the auxiliary material consisting of more than two kinds.
(5) 살균 처리 과정(5) sterilization process
상기 살균 처리 과정(S150)은 부원료가 혼합된 농축엑스 내에 잔존하고 있는 미세균을 제거하기 위한 과정이다. The sterilization process (S150) is a process for removing microorganisms remaining in the concentrated extract mixed with subsidiary materials.
상기 살균 처리 과정(S150)은 96 ~ 98℃에서 15 ~ 20초간 가열하여 이루어진다. The sterilization process (S150) is made by heating for 15 to 20 seconds at 96 ~ 98 ℃.
(6) 충진/밀봉 과정(6) filling / sealing process
상기 충진/밀봉 과정(S160)은 살균 처리된 혼합액을 미리 설정된 용기에 넣고 밀봉시키는 과정이다. 상기 용기로는 세척이 완료된 공병이나 캔 등을 이용할 수 있다. The filling / sealing process (S160) is a process of putting the sterilized mixed liquid into a predetermined container and sealing it. As the container, it is possible to use an empty bottle or a can which has been washed.
(7) 저온 살균 과정(7) pasteurization process
상기 저온 살균 과정(S170)은 밀봉된 용기를 비교적 저온에서 2차 살균 처리하는 과정이다. The pasteurization process S170 is a process of secondary sterilization at a relatively low temperature in a sealed container.
상기 저온 살균 과정(S170)은 밀봉된 용기를 85℃에서 15분간 살균시켜 이루어진다. The pasteurization process S170 is performed by sterilizing the sealed container at 85 ° C. for 15 minutes.
도 2 내지 도 4는 본 발명의 바람직한 실시예에 따라 제조된 숙취 해소용 음료 및 비교예에 따라 제조된 음료를 각각 실험용 쥐에 경구 투여하여 전처리하고 일정 시간 경과후 알코올을 경구 투여하여 얻어진 혈장 중 알코올 농도-시간 곡선이다. 2 to 4 are plasma treatment obtained by orally administering a hangover drink prepared in accordance with a preferred embodiment of the present invention and a beverage prepared according to a comparative example, respectively, by pretreatment and oral administration of alcohol after a certain time. Alcohol concentration-time curve.
도 2는 실험용 쥐에 생리식염수, 본 발명의 실시예에 따른 숙취 해소용 음료 및 비교예에 따른 음료(컨디션)를 경구 투여하여 전처리하고 30분 경과후 알코올을 1.0 g/kg 경구 투여하여 얻어진 혈장중 알코올 농도-시간 곡선이다. 도면에서 보는 바와 같이 본 발명의 숙취 해소용 음료군에서의 혈장중 알코올 농도가 생리식염수군이나 비교예군보다 낮은 것을 알 수 있다. 이중 5, 10, 15, 30, 45, 60분에서의 숙취 해소용 음료군의 농도는 생리식염수군의 농도보다 유의성있게 낮게 나타났다. 2 is a plasma obtained by orally administering saline, a hangover drink according to an embodiment of the present invention, and a beverage (condition) according to a comparative example, orally administered 1.0 g / kg of alcohol after 30 minutes to the experimental rat. Heavy alcohol concentration-time curve. As shown in the figure it can be seen that the plasma alcohol concentration in the hangover drink group of the present invention is lower than the physiological saline group or the comparative example group. The concentration of the hangover drink group at 5, 10, 15, 30, 45, and 60 minutes was significantly lower than that of the physiological saline group.
한편, 본 발명의 숙취 해소용 음료에는 농축엑스와 아울러 간 기능 보조작용을 갖는 타우린이 함유되어 있어, 유의성있게 낮게 나타난 혈장중 알코올 농도가 농축엑스에 의한 것임을 밝히기 위해 농축엑스만을 제외하고 제조된 숙취 해소용 음료를 제4동물군(타우린군)에 투여하였으며 이때 얻은 결과를 생리식염수군과 비교하여 도 3에 나타내었다. 생리식염수군과 타우린군 간의 혈장중 알코올 농도 추이에는 유의성있는 차이가 발견되지 않았으며, 따라서 도 2에 나타난 본 발명의 숙취 해소용 음료의 낮은 혈장중 알코올 농도는 타우린에 의한 것이 아니고, 농축엑스에 의한 것임을 알 수 있다. Meanwhile, the hangover-removing drink of the present invention contains taurine having a concentrated function as well as a liver function, so that the alcohol concentration in the plasma, which is significantly lower, is found to be due to the concentrated extract. The dissolution drink was administered to the fourth animal group (taurine group) and the results obtained are shown in FIG. 3 in comparison with the physiological saline group. No significant difference was found in the plasma alcohol concentration trend between the physiological saline group and the taurine group. Therefore, the low plasma alcohol concentration of the hangover drink of the present invention shown in FIG. 2 is not caused by taurine and is concentrated in extract. It can be seen that.
또한, 도 4는 실험용 쥐에 생리식염수, 본 발명인 숙취 해소용 음료 및 비교예를 경구 투여하여 전처리하고, 30분 경과후 알코올을 3.0 g/kg 경구 투여하여 얻어진 혈장중 알코올 농도-시간 곡선이다. 도면에서 보는 바와 같이 본 발명인 숙취 해소용 음료군에서의 혈장중 알코올 농도가 생리식염수군이나 컨디션군보다 낮은 것을 알 수 있다. 4 is a plasma alcohol concentration-time curve obtained by oral administration of physiological saline, a hangover solution of the present invention, and a comparative example to an experimental rat, and 3.0 g / kg oral administration of alcohol after 30 minutes. As shown in the figure, it can be seen that the plasma alcohol concentration in the present hangover solution group is lower than the physiological saline group or the condition group.
<실시예><Example>
갈화, 진피, 은행, 박하를 세척한 후 10배의 정제수를 가하고, 90℃에서 2시간동안 추출하였다. 이어, 추출액을 여과하고 60℃ 이하에서 감압 농축하여 농축엑스를 얻었으며, 이를 정제수에 용해하였다. 이때, 농축엑스의 배합비율은 갈화 13.0%, 진피 22.6%, 은행 32.2%, 박하 32.2%로 유지하였다.After washing the grinding, dermis, ginkgo and mint, 10 times purified water was added and extracted at 90 ° C. for 2 hours. Then, the extract was filtered and concentrated under reduced pressure at 60 ℃ or less to obtain a concentrated extract, which was dissolved in purified water. At this time, the mixing ratio of the concentrated extract was maintained at 13.0% browning, 22.6% dermis, 32.2% ginkgo, 32.2% mint.
이어, 백설탕, 사과과즙, 타우린, 액상과당, 스테비오사이드, 염화나트륨, 구연산나트륨, 베타-시클로덱스트린, 소드-글루타메이트를 정제수에 넣고 용해한 후 여과한다. 이때, 배합비율은 농축엑스 4.0%, 정제수 81.226%, 백설탕 5.333%, 사과과즙 4.0%, 타우린 0.667%, 액상과당 3.333%, 스테비오사이드 0.024%, 염화나트륨 0.04%, 구연산나트륨 0.04%, 베타-시클로덱스트린 1.267%, 소드-글루타메이트 0.02%로 각각 조절하였다. 이어, 혼합액을 97℃에서 20초간 살균한 후 미리 세척된 공병에 충진하여 캡으로 밀봉하였다. Then, white sugar, apple juice, taurine, liquid fructose, stevioside, sodium chloride, sodium citrate, beta-cyclodextrin, and sodium glutamate are added to purified water, dissolved, and filtered. In this case, the compounding ratio was 4.0% concentrated extract, 81.226% purified water, 5.333% white sugar, apple juice 4.0%, taurine 0.667%, liquid fructose 3.333%, stevioside 0.024%, sodium chloride 0.04%, sodium citrate 0.04%, beta-cyclodextrin 1.267% and 0.02% of Saw-glutamate, respectively. Subsequently, the mixed solution was sterilized at 97 ° C. for 20 seconds, and then filled in a previously washed empty bottle and sealed with a cap.
상술한 바와 같이 본 발명의 실시예에 따른 숙취 해소용 음료 및 그 제조 방법은 에틸알콜의 중추신경에 대한 작용을 완화시켜 숙취로 인한 판단능력, 기억력, 집중력, 이해력 저하를 감소시키는 효과가 있다.As described above, the hangover drink and its preparation method according to the embodiment of the present invention has the effect of reducing the ability to judge, memory, concentration, comprehension caused by hangover by relieving the action of the central alcohol of the ethyl alcohol.
또한, 본 발명의 실시예에 따른 숙취 해소용 음료 및 그 제조 방법은 심율을 낮추고 심근의 산소 소모량을 감소시키며, 심력의 장력을 낮추어 숙취로 인한 심장의 부담을 경감시키는 효과가 있다. In addition, the hangover drink and the preparation method according to an embodiment of the present invention has the effect of reducing the heart rate due to a hangover by lowering the heart rate, reducing the oxygen consumption of the myocardium, lowering the tension of the heart.
또한, 본 발명의 실시예에 따른 숙취 해소용 음료 및 그 제조 방법은 위점막 모세혈관의 혈관 투과성을 저하시킴으로써 위점막을 보호하고, 위장벽 평활근의 긴장성을 저하시켜 위장운동 절주를 느리게 하며, 아세트알데히드의 구토 증상을 감소시키는 효과가 있다. In addition, the hangover drink and the preparation method according to an embodiment of the present invention protects the gastric mucosa by lowering the vascular permeability of gastric mucosa capillaries, slows the gastrointestinal wall smooth muscle tension to slow gastrointestinal motility, acet It is effective in reducing the symptoms of vomiting of aldehydes.
도 1은 본 발명의 바람직한 실시예에 따른 숙취 해소용 음료의 제조 방법을 나타낸 흐름도,1 is a flow chart showing a method for producing a hangover drink in accordance with a preferred embodiment of the present invention,
도 2 내지 도 4는 본 발명의 바람직한 실시예에 따라 제조된 숙취 해소용 음료 및 비교예에 따라 제조된 음료를 각각 실험용 쥐에 경구 투여하여 전처리하고 일정 시간 경과후 알코올을 경구 투여하여 얻어진 혈장 중 알코올 농도-시간 곡선.2 to 4 are plasma treatment obtained by orally administering a hangover drink prepared in accordance with a preferred embodiment of the present invention and a beverage prepared according to a comparative example, respectively, by pretreatment and oral administration of alcohol after a certain time. Alcohol concentration-time curve.
<도면의 주요 부분에 대한 부호의 설명><Explanation of symbols for the main parts of the drawings>
S110 : 추출 과정 S120 : 여과/감압 농축 과정S110: Extraction Process S120: Filtration / Decompression Concentration Process
S130 : 용해 과정 S140 : 부원료 혼합/여과 과정S130: Dissolution Process S140: Submaterial Mix / Filter Process
S150 : 살균 처리 과정 S160 : 충진/밀봉 과정S150: Sterilization Process S160: Filling / Sealing Process
S170 : 저온 살균 과정S170: Pasteurization Process
Claims (7)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1020030070489A KR20050034802A (en) | 2003-10-10 | 2003-10-10 | Drink for withdrrawl of hangover and fabrication method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1020030070489A KR20050034802A (en) | 2003-10-10 | 2003-10-10 | Drink for withdrrawl of hangover and fabrication method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| KR20050034802A true KR20050034802A (en) | 2005-04-15 |
Family
ID=37238492
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020030070489A KR20050034802A (en) | 2003-10-10 | 2003-10-10 | Drink for withdrrawl of hangover and fabrication method thereof |
Country Status (1)
| Country | Link |
|---|---|
| KR (1) | KR20050034802A (en) |
Citations (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR950007867A (en) * | 1993-09-22 | 1995-04-15 | 성우경 | Herbal composition for prevention and treatment of hangover symptoms |
| KR950016541A (en) * | 1993-12-30 | 1995-07-20 | 김춘란 | Healthy tea and its manufacturing method |
| KR960016779A (en) * | 1994-11-14 | 1996-06-17 | 강성훈 | Health mixed drink composition |
| KR20000066777A (en) * | 1999-04-21 | 2000-11-15 | 김정희 | Dynamic drink for removal of foul breath and hangover, and recovery from fatigue, and method of preparing the same |
| KR20010019767A (en) * | 1999-08-30 | 2001-03-15 | 송병식 | Natural tea for preventing hangover and preparation method thereof |
| KR20010064835A (en) * | 1999-12-20 | 2001-07-11 | 장상근 | Tea and manufacture of tea for alcohol remove |
| KR20020048212A (en) * | 2000-12-16 | 2002-06-22 | 김용기 | Beverage for Curing Hangover and Manufacturing Method thereof |
| KR20020092562A (en) * | 2001-06-04 | 2002-12-12 | 정풍한방제약주식회사 | Functional beverage, tea composition and a preparation process thereof |
-
2003
- 2003-10-10 KR KR1020030070489A patent/KR20050034802A/en active Search and Examination
Patent Citations (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR950007867A (en) * | 1993-09-22 | 1995-04-15 | 성우경 | Herbal composition for prevention and treatment of hangover symptoms |
| KR950016541A (en) * | 1993-12-30 | 1995-07-20 | 김춘란 | Healthy tea and its manufacturing method |
| KR960016779A (en) * | 1994-11-14 | 1996-06-17 | 강성훈 | Health mixed drink composition |
| KR20000066777A (en) * | 1999-04-21 | 2000-11-15 | 김정희 | Dynamic drink for removal of foul breath and hangover, and recovery from fatigue, and method of preparing the same |
| KR20010019767A (en) * | 1999-08-30 | 2001-03-15 | 송병식 | Natural tea for preventing hangover and preparation method thereof |
| KR20010064835A (en) * | 1999-12-20 | 2001-07-11 | 장상근 | Tea and manufacture of tea for alcohol remove |
| KR20020048212A (en) * | 2000-12-16 | 2002-06-22 | 김용기 | Beverage for Curing Hangover and Manufacturing Method thereof |
| KR20020092562A (en) * | 2001-06-04 | 2002-12-12 | 정풍한방제약주식회사 | Functional beverage, tea composition and a preparation process thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP5314345B2 (en) | Curcumin-containing turmeric drink excellent in dispersibility and precipitation stability and method for producing the same | |
| US20060068043A1 (en) | Composition for treating chronic venous insufficiencies using an extract of red vine leaves | |
| JP4589212B2 (en) | Proanthocyanidin-containing food and process for producing the same | |
| CN103284242A (en) | Beverage for dispelling effects of alcohol | |
| CN103251698B (en) | Puerarin beverage with effects of dispelling alcoholism, protecting liver and protecting stomach and preparation method thereof | |
| KR100635025B1 (en) | A ginseng preparation using vinegar and process for thereof | |
| CN101463314B (en) | Non-intoxicated liquor and preparation of antialcoholism nutrient fluid therefor | |
| KR100706465B1 (en) | cocktail for hangover remedy | |
| KR20080085418A (en) | Matured liqueur making method in oak bottle using leaching incubated wild ginseng root | |
| KR20210012982A (en) | Method of manufacturing mulberry leaf extract using lactic acid bacteria fermentation, and mulberry leaf extract manufactured by the method | |
| CN1201667C (en) | Pu'er tea beverage | |
| CN1229131A (en) | Health-care beer added with bamboo leaf flavone extract | |
| KR20050034802A (en) | Drink for withdrrawl of hangover and fabrication method thereof | |
| KR20080105510A (en) | Drink for withdrawal of hangover and fabrication method thereof | |
| KR20030097173A (en) | Red ginseng drink | |
| KR20000072393A (en) | Method for Preparation of Spirits Added With Plum | |
| KR20090091653A (en) | Composition for relieving and preventing hangover | |
| CN111387321A (en) | Fruit scented tea beverage and preparation method thereof | |
| CN111991503A (en) | Production process of snake gall and bulbus fritilariae liquid | |
| CN108720013A (en) | The formula and processing technology of the health food of one group of Soboring-up liver-protecting being made of fructose and tea extract | |
| JP4305806B2 (en) | Anti-stress agent | |
| CN108514123A (en) | The active peptides extracted from blood clam prepare compound method | |
| CN110074227A (en) | A kind of herbal tea drink prescription and preparation method | |
| CN100352909C (en) | Glossy ganoderma juice wine and its preparing method | |
| KR20190098434A (en) | Soybeam source composition using Dendropanax morbifera extract and Method including the same |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A201 | Request for examination | ||
| E902 | Notification of reason for refusal | ||
| AMND | Amendment | ||
| E90F | Notification of reason for final refusal | ||
| AMND | Amendment | ||
| E601 | Decision to refuse application | ||
| J201 | Request for trial against refusal decision | ||
| AMND | Amendment | ||
| E801 | Decision on dismissal of amendment | ||
| B601 | Maintenance of original decision after re-examination before a trial | ||
| J501 | Disposition of invalidation of trial | ||
| J301 | Trial decision |
Free format text: TRIAL DECISION FOR APPEAL AGAINST DECISION TO DECLINE REFUSAL REQUESTED 20060328 Effective date: 20070327 |